Delivery Order SPE2DB20D1109-SPE2DB25FP67U
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,478.27. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with a contract ceiling value of $4,365.39. This is a firm fixed price delivery order under a competitively awarded, non-set-aside contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $2,855.75. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. The contract is scheduled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a ceiling value of $1,346.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on April 25, 2025, and performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery...
- AmerisourceBergen Drug Corp received a delivery order from the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets in quantities of 100 units, with a contract ceiling value of $3,523.73. The award, which is non-competitive and represents a child contract under a larger vehicle, is scheduled for completion by September 4, 2025. This delivery order operates under a firm fixed price structure and will be performed at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with a ceiling value of $2,358.46. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania, and is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a contract value of $2,003.69. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under the company's existing federal contract vehicle. The work is to be completed by September 22, 2025, with performance based in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $3,250.47. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count) with a contract value of $2,307.76. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP67UDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) under a firm fixed-price contract valued at $2,729.30. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. The award was competitively awarded with no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order supports the military healthcare supply chain by providing a controlled substance commonly used in the treatment of attention-deficit/hyperactivity disorder (ADHD) across Defense Health Agency and military medical facilities. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts demonstrates its capability to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The firm fixed-price structure and completion date of September 4, 2025, indicate a routine medical supply delivery meeting established federal procurement requirements within DLA's medical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/3/25 |